T10	Drug 752 755	DOX
T11	Drug 762 772	paclitaxel
T12	Disease 739 796	doxorubicin (DOX)- and paclitaxel-resistant breast cancer
#3	AnnotatorNotes T12	not found
T13	Disease 846 852	cancer
T16	Disease 1054 1060	cancer
T18	Disease 1118 1124	cancer
T2	Disease 263 276	neuroblastoma
#8	AnnotatorNotes T2	DOID:769
T21	Drug 1262 1272	paclitaxel
T22	Disease 1287 1301	gastric cancer
#10	AnnotatorNotes T22	DOID:10534
T3	Disease 294 300	cancer
#11	AnnotatorNotes T3	DOID:162
T5	Disease 444 450	cancer
T6	Drug 498 509	gemcitabine
T7	Drug 533 544	gemcitabine
T8	Disease 553 570	pancreatic cancer
#15	AnnotatorNotes T8	DOID:1793
T9	Drug 739 750	doxorubicin
T1	RNA-Noncoding 80 90	miR-155-5p
#1	AnnotatorNotes T1	HGNC:31542
T4	RNA-Noncoding 211 221	miR-155-5p
T14	Biomarker 202 221	exosomal miR-155-5p
R1	Association Arg1:T14 Arg2:T30	
T15	RNA-Noncoding 395 405	miR-155-5p
T19	Biomarker 395 440	miR-155-5p expression levels were upregulated
#2	AnnotatorNotes T6	CHEMBL888
T20	RNA-Noncoding 642 652	miR-155-5p
T23	Biomarker 642 652	miR-155-5p
#9	AnnotatorNotes T23	C524942
#12	AnnotatorNotes T9	CHEMBL53463
#13	AnnotatorNotes T10	CHEMBL53463
#14	AnnotatorNotes T11	CHEMBL428647
T24	Biomarker 883 893	miR-155-5p
T25	RNA-Noncoding 883 893	miR-155-5p
T26	RNA-Noncoding 934 944	miR-155-5p
T27	Biomarker 925 944	exosomal miR-155-5p
R3	Association Arg1:T27 Arg2:T16	
T17	Biomarker 1138 1157	exosomal miR-155-5p
T28	Biomarker 1213 1232	exosomal miR-155-5p
T29	Collection 739 772	doxorubicin (DOX)- and paclitaxel
R4	Mediated-Non-Response Arg1:T29 Arg2:T13	
R5	Mediator Arg1:T29 Arg2:T24	
T30	Collection 263 300	neuroblastoma cells to promote cancer
R6	Mediated-Non-Response Arg1:T7 Arg2:T8	
R7	Mediator Arg1:T7 Arg2:T23	
